https://www.avient.com/knowledge-base/article/selecting-and-molding-high-performance-thermoplastics
Save and share the full eBook as a PDF for future reference.
Download PDF
https://www.avient.com/investor-center/news/avient-announces-record-first-quarter-2021-results-increases-full-year-guidance
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/2023-05/Mevopur Healthcare Colorants and Formulations Amber for Pharma Application Bulletin.pdf
An addition to the Mevopur™ portfolio is a pre-tested amber concentrate for PET vials, bottles and other packaging products.
Mevopur Healthcare Colorants and Formulations in amber tones provide the safety of pre-tested raw materials while protecting and prolonging the shelf life of pharmaceuticals and nutraceuticals in amber PET packaging products.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com
https://www.avient.com/news/avient-s-malm-sweden-site-earns-iscc-plus-certification-mevopur-healthcare-bio-based-polymer-solutions
Homepage
//
News Center
//
Avient’s Malmö, Sweden Site Earns ISCC PLUS Certification for Mevopur™ Healthcare Bio-based Polymer Solutions
Mevopur™ Healthcare Bio-based Polymer Solutions manufactured in Malmö, Sweden, are now ISCC PLUS certified.
Like other Mevopur products, the bio-based polymer solutions are formulated with raw materials pre-tested to ISO, USP, EP, and ICH Q3D protocols, supporting their compliance with safety and regulatory requirements for use in healthcare.
https://www.avient.com/sites/default/files/2022-05/MEVOPUR LQ for Silicone Elastomers_CN.pdf
MEVOPUR LQ for Silicone Elastomers_CN5.17-1 MEVOPUR™ LQ 应用于硅橡胶的液体着色剂和添加剂母粒 应用公告 硅橡胶由于其独特的物理特性组合,例如强度、 耐受度及灵活性等,同时作为一种通过最多生物 相容性及低致敏性测试的聚合物之一,成为了多 种医疗应用的首选材料。
MEVOPUR™ LQ 系列先进的液体着色剂和添加剂 母粒使用与硅橡胶高度相容的特定液体载体系 统。
可根据要求提供多种定制化 颜色解决方案 根据ISO 13485/GMP质量体系生产,并拥有变 更控制管理 原材料红外光谱分析和常规批次检测 根据ISO 10993第18部分对正己烷、异丙醇及 水中的可萃取性进行评估 • • • • 法规支持 原材料根据ISO 10993-1和USP第、 章(VI类)对原材料进行生物评估的预测试 向FDA提交所有标准颜色的DMF/MAF文件 • • 应用 医疗器械,如导管和连接器、注射器针头及无 针连接器 与皮肤接触设备,如可穿戴设备或医疗器械的 柔软触感表面 • • MEVOPUR LQ 配方可用于要求严苛的应用,包 括: MEVOPUR™-LQ 不透明红(PMS198C) 产品编号:FZ3M415008 MEVOPUR™-LQ 透明红 产品编号:FZ3M415009 MEVOPUR™-LQ 不透明蓝(PMS292C) 产品编号:FZ5M415008 MEVOPUR™-LQ 透明蓝 产品编号:FZ5M415009 MEVOPUR™-LQ 不透明黄(PMS1205C) 产品编号:FZ1M415005 MEVOPUR™-LQ 透明黄 产品编号:FZ1M415006 MEVOPUR™-LQ 不透明绿(PMS346C) 产品编号:FZ6M415008 MEVOPUR™-LQ 透明绿 产品编号:FZ6M415009 MEVOPUR™-LQ 不透明紫(PMS2655C) 产品编号:FZ4M415003 MEVOPUR™-LQ 透明紫 产品编号:FZ4M415004 定制化选择 也可以根据您的需求 定制颜色, 请联系我们。
https://www.avient.com/sites/default/files/2025-04/Supplier Code of Conduct FV_Eng.pdf
Health and Safety • Implement appropriate processes and procedures to ensure that human health and safety are at the forefront of your actions.
This includes measuring performance and setting appropriate goals to promote continuous improvement. • Comply with all applicable environmental, health, safety, and security regulations.
Version: May 2025 mailto:sourcing@avient.com Health and Safety Environment Social Ethics and Governance Management Systems
https://www.avient.com/sites/default/files/2022-05/AVNT May IR Presentation w Non GAAP Recs.pdf
Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”).
To provide comparable financial results, the Company references “pro forma” financial metrics, which include the business results of Clariant Color for periods prior to the Acquisition Date.
Financials are pro forma for the acquisition of Dyneema® and potential divestiture of Distribution Avient Specialty Formulators Other Specialty / Chemical Companies 45 Source: Peer data per Bloomberg market data as of April 21, 2022 Total Enterprise Value / NTM EBITDA With the Dyneema and Clariant Color business acquisition and divestment of the PP&S business, along with the proposed sale of our Distribution business, our exposure is now concentrated in less-cyclical and high-growth markets.
https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2020-results-and-provides-guidance-2021
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets (Unaudited)
https://www.avient.com/sites/default/files/2022-03/Avient 2022 Proxy Statement.pdf
Safety and Health The top priority at Avient is the safety and health of our associates and our ultimate goal is to operate injury free.
The second independent source of data that we used to augment the peer proxy analysis was the Consultantʼs analysis of competitive market data relating to other applicable general industries.
The CEO makes his recommendations in conjunction with the marketplace data.
https://www.avient.com/sites/default/files/2023-01/Mevopur Colorants _ Additives Brochure.pdf
HEALTHCARE POLYMER SOLUTIONS Mevopur™ Healthcare Colorants & Formulations Mevopur™ Healthcare Functional Additives Sustainability Spotlight Human Health & Safety MITIGATING RISK AT EVERY STAGE OF DESIGN AND PRODUCTION Mevopur™ polymer solutions are trusted products and services developed to help medical device, diagnostics and pharmaceutical packaging sectors meet the growing challenges of product consistency, compliance and reliability.
Mevopur products cover the wide range of polymers and thermoplastic elastomers (TPEs) used in the medical and pharmaceutical sectors.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com